We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+7.05%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.14B
AUM Growth
+$78M
Cap. Flow
+$4.03M
Cap. Flow %
0.35%
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7

Top Buys

Rank Stock Value
1
AVUV icon
Avantis US Small Cap Value ETF
AVUV
+$3.94M
2
VTEB icon
Vanguard Tax-Exempt Bond Index Fund
VTEB
+$3.93M
3
NMRA icon
Neumora Therapeutics
NMRA
+$3.31M
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$2.97M
5
MSFT icon
Microsoft
MSFT
+$2.45M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$16M
2
SCHB icon
Schwab US Broad Market ETF
SCHB
+$5.85M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.04M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.44M
5
EW icon
Edwards Lifesciences
EW
+$2.12M

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.4%
2 Technology 5.18%
3 Healthcare 2.32%
4 Financials 1.59%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPST icon
301
JPMorgan Ultra-Short Income ETF
JPST
$40.8B
– –
-18,784
Closed -$944K
XBI icon
302
State Street SPDR S&P Biotech ETF
XBI
$11.3B
– –
-3,958
Closed -$353K
EFTR
303
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
– –
-800
Closed -$9.35K
MRTX
304
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-6,431
Closed -$378K
9 10 11 12
13

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Callan Capital held 304 positions worth $1.14B, up 7.4% from $1.06B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Callan Capital's Q1 2024 filing shows 70 new, 124 increased, 70 reduced and 7 closed positions. Its largest new stake was Neumora Therapeutics: 204,987 shares worth $2.82M. The largest sale was NVIDIA, an estimated $16M.

By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, down from 88% a quarter earlier, followed by Technology and Healthcare.

  • Callan Capital's largest Q1 2024 buy was Neumora Therapeutics: 204,987 shares worth $2.82M.
  • Callan Capital added most to Avantis US Small Cap Value ETF in Q1 2024, an estimated $3.94M increase.
  • Callan Capital's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $16M.
  • Callan Capital fully exited Edwards Lifesciences in Q1 2024, selling an estimated $2.12M.
  • Callan Capital's ten largest holdings make up 49% of its $1.14B portfolio in Q1 2024.
  • Callan Capital opened 70 new positions and closed 7 in Q1 2024.
  • Callan Capital's portfolio value rose 7.4% quarter-over-quarter to $1.14B.

Based on Callan Capital's 13F filing for Q1 2024, filed 3 May 2024.